Go to article
Posted by CoV Report on September 21, 2021 6:30 amTags: Categories: US National Stories
Johnson & Johnson shared data from its Phase 3 trial of the company’s booster shot on Tuesday. The data showed a booster shot at six months provided a 12-fold increase in antibodies.
(Image credit: Eva Marie Uzctegui/Bloomberg via Getty Images)
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
< The Coronavirus Report home
Everything you need to know to stay updated on the Coronavirus
Leave a Reply